Japan· JP-2190406A2124
アルプロスタジル
A alprostadil product containing アルプロスタジル, registered in Japan by 富士製薬工業, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Alprostadil is registered in 10 of 19 countries.
Countries holding a registration under ATC C01EA01 (alprostadil), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Alprostadil · ATC C01EA01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アルプロスタジル
- Manufacturer
- 富士製薬工業
- Country
- Japan (JP)
- ATC code
- C01EA01
- ATC class
- Alprostadil
- Defined daily dose
- 0.5 mg, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
84 interactions on record for alprostadil.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alprostadil · interactions on record
84 records
- 22 moderate
- 62 info
Most severe, free to view
- LorcaserinA08AA11moderate
- DapagliflozinA10BK01moderate
- CanagliflozinA10BK02moderate
- EmpagliflozinA10BK03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01EA01
Alprostadil, as other registers publish it.
- DenmarkAlprostadil CarefarmOrifarm A/S
- SwitzerlandALPROSTADIL Leman IV 500 mcg/ml, solution à diluer pour perfusionLeman SKL SA
- CzechiaALPROSTANZentiva, k.s., Praha
- DenmarkNeupedixOresund Pharma ApS
- FinlandNeupedixOresund Pharma ApS (Øresund Pharma)
- NetherlandsPropedix 0,5 mg/ml concentraat voor oplossing voor infusieOresund Pharma ApS
- BelgiumPropedix 0.5 mg/mlOresund Pharma
- CzechiaPROSTAVASINAMDIPHARM LIMITED, Dublin
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be4d4a25-e764-4afd-a81b-deb6cd43411a GET /v1/drugs/be4d4a25-e764-4afd-a81b-deb6cd43411a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０μｇ２ｍＬ１管",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2190406A2124",
"category": "注射薬",
"price_yen": 830,
"generic_name": "アルプロスタジル",
"product_name_jp": null,
"therapeutic_class": "2190",
"transitional_expiry": null
}See everything about alprostadil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.